Global Blood Therapeutics, Inc.
Modulators of hemoglobin
Last updated:
Abstract:
The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.
Status:
Grant
Type:
Utility
Filling date:
18 Nov 2019
Issue date:
16 Jun 2020